Advertisement
Section edited by Sanjay Chotirmall and Giovanni Sotgiu
This section concerns all aspects of pulmonary infection, rare and idiopathic lung diseases including, but not limited to: prevention, diagnosis and management, as well as related molecular genetics, and pathophysiology.
Research article
Two antifibrotic drugs, pirfenidone and nintedanib, are approved by the European Medicines Agency and the US Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis (IPF). In this analy...
BMC Pulmonary Medicine 2017 17:124
Published on: 15 September 2017
Research article
Late-onset noninfectious pulmonary complications (LONIPCs), which occur more than 3 months after allogeneic hematopoietic stem cell transplantation (HSCT), are major causes of morbidity and mortality after tra...
BMC Pulmonary Medicine 2017 17:123
Published on: 7 September 2017
Study protocol
Pirfenidone is currently approved in the EU for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) and offers a beneficial risk-benefit profile. However, there are several other, progressive...
BMC Pulmonary Medicine 2017 17:122
Published on: 6 September 2017
Research article
To identify the prognostic factors for survival in patients with interstitial pneumonia with autoimmune features (IPAF) who meet the serological domain of the IPAF criteria.
BMC Pulmonary Medicine 2017 17:111
Published on: 14 August 2017
Case report
Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome, lymphangioleiomyomatosis/tuberous sclerosis complex (LAM-TSC), and sarcoidosis are three rare diseases. Here we present, to the best of our know...
BMC Pulmonary Medicine 2017 17:107
Published on: 28 July 2017
Research article
Physical activity (PA) is associated with disease severity in idiopathic pulmonary fibrosis (IPF), but longitudinal studies evaluating its prognostic value and changes over time are lacking.
BMC Pulmonary Medicine 2017 17:104
Published on: 25 July 2017
Research article
The role of CD4+CD25highCD127− T-reg cells in solid-organ Transplant (Tx) acceptance has been extensively studied. In previous studies on kidney and liver recipients, peripheral T-reg cell counts were associated ...
BMC Pulmonary Medicine 2017 17:102
Published on: 18 July 2017
Case report
Burkholderia cepacia complex is a group of opportunistic pathogens in cystic fibrosis (CF) patients believed to be associated with poor prognosis and patient-to-patient transmissibilit...
BMC Pulmonary Medicine 2017 17:100
Published on: 14 July 2017
Research article
This study aimed to investigate the effects of regulating autonomic nervous system (ANS) homeostasis by inhibiting sympathetic hyperactivity and/or enhancing parasympathetic activity on pulmonary inflammation ...
BMC Pulmonary Medicine 2017 17:98
Published on: 3 July 2017
Research article
Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE...
BMC Pulmonary Medicine 2017 17:96
Published on: 29 June 2017
Research article
Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a fatal condition without an established pharmaceutical treatment. Most patients are treated with high-dose corticosteroids and broad-spectrum ...
BMC Pulmonary Medicine 2017 17:94
Published on: 19 June 2017
Research article
The aim of the present study was to evaluate the association of NRAMP1 -3′UTR, 274-CT,VDR- Fok1 VDR-Taq1 Polymorphisms with the risk of pulmonary tuberculosis.
BMC Pulmonary Medicine 2017 17:89
Published on: 5 June 2017
Research article
Xpert MTB/Rif (Xpert) is described as a game changer in tuberculosis (TB) control. We evaluated the impact of Xpert on diagnosis, time to treatment, and treatment outcome among patients with HIV associated TB ...
BMC Pulmonary Medicine 2017 17:87
Published on: 30 May 2017
Case report
Sarcoidosis presents with typical clinic-radiological findings and shows histologically non-caseating granulomas. Pulmonary manifestations of sarcoidosis can be diverse, involving the intrathoracic lymph nodes...
BMC Pulmonary Medicine 2017 17:88
Published on: 30 May 2017
Research article
Chronic hypersensitivity pneumonitis (CHP) has a variable disease course. Computer analysis of CT features was used to identify a subset of CHP patients with an outcome similar to patients with idiopathic pulm...
BMC Pulmonary Medicine 2017 17:81
Published on: 4 May 2017
Research article
To date, only few studies have examined the prognostic factors of community-acquired pneumonia (CAP) defined according to the latest criteria, which excludes healthcare-associated pneumonia (HCAP). Therefore, ...
BMC Pulmonary Medicine 2017 17:78
Published on: 2 May 2017
Case report
Fungi can cause a variety of infectious diseases, including invasive mycosis and non-invasive mycosis, as well as allergic diseases. The different forms of mycosis usually have been described as mutually exclu...
BMC Pulmonary Medicine 2017 17:76
Published on: 28 April 2017
Research article
Chronic inflammation emerges as a feature of the pathogenesis of pulmonary arterial hypertension (PAH) in experimental models. Alterations of circulating cell subsets have been observed in patients with PAH. W...
BMC Pulmonary Medicine 2017 17:72
Published on: 26 April 2017
Research article
The FACED score is an easy-to-use multidimensional grading system that has demonstrated an excellent prognostic value for mortality in patients with bronchiectasis. A Spanish group developed the score but no m...
BMC Pulmonary Medicine 2017 17:73
Published on: 26 April 2017
Research article
Tuberculosis (TB) is a major global health problem, and there is an association between tobacco smoke and TB. Water pipe smoking has become an increasing problem not only in Middle Eastern countries but also g...
BMC Pulmonary Medicine 2017 17:68
Published on: 21 April 2017
